Pediatrix Medical (MD) Receivables - Other (2017 - 2024)

Pediatrix Medical has disclosed Receivables - Other across 8 years of filings, most recently posting $28.5 million for Q4 2024.

• In Q4 2024, Receivables - Other fell 14.16% year-over-year to $28.5 million; the TTM figure through Dec 2024 stood at $28.5 million (down 14.16% YoY), while the FY2024 annual figure was $28.5 million, down 14.16% from the prior year.
• Receivables - Other fell to $28.5 million in Q4 2024, from $33.2 million in the prior quarter.
• Over the last five years, Receivables - Other for MD reached as high as $61.4 million in Q4 2020 and fell as low as $28.5 million in Q4 2024.
• The 5-year median for Receivables - Other is $54.7 million (2022), against an average of $47.2 million.
• Annual changes were most pronounced in 2020 — Receivables - Other surged 106.04% — and 2023, when it plunged 39.31%.
• A 5-year view of Receivables - Other shows it stood at $61.4 million in 2020, then slipped by 5.37% to $58.1 million in 2021, then fell by 5.85% to $54.7 million in 2022, then sank by 39.31% to $33.2 million in 2023, then retreated by 14.16% to $28.5 million in 2024.
• According to Business Quant data, Receivables - Other over the past three periods registered $28.5 million, $33.2 million, and $54.7 million for Q4 2024, Q4 2023, and Q4 2022 respectively.